作者
Arnaud Méjean,Alain Ravaud,Simon Thézenas,Sandra Colas,Jean‐Baptiste Beauval,Karim Bensalah,Lionnel Geoffrois,Antoine Thiery-Vuillemin,Laurent Cormier,Hervé Lang,Laurent Guy,Gwénaëlle Gravis,Frédéric Rolland,Claude Linassier,É. Lechevallier,Christian Beisland,Michael Aitchison,Stéphane Oudard,Jean‐Jacques Patard,C Théodore,Christine Chevreau,Brigitte Laguerre,Jacques Hubert,Marine Gross‐Goupil,Jean‐Christophe Bernhard,Laurence Albigès,Marc‐Olivier Timsit,Thierry Lebrét,Bernard Escudier
摘要
Cytoreductive nephrectomy has been the standard of care in metastatic renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies. However, the efficacy of targeted therapies has challenged this standard. We assessed the role of nephrectomy in patients with metastatic renal-cell carcinoma who were receiving targeted therapies.
爱静静
寻道图强
乐乐乐乐乐乐
Frank
kento
yyymmma
樱桃猴子
fendy
Billy
浅尝离白
吃不饱星球球长
万能图书馆
共享精神
shinysparrow
清脆松
tuanheqi
sissiarno
timemaster666
领导范儿
Singularity
皖公网安备34019202002308
